Navigating Preclinical Drug Development Challenges with Lipid-Based Formulations
Summary: Download this executive summary to explore key insights from industry experts on critical considerations and strategies for dosing lipid formulations in preclinical models, along with an overview of the regulatory and technical nuances involved in advancing preclinical lipid-based formulations (LBF) to viable clinical dosage forms.